| Li, Ping |
NCT06381323: The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism |
|
|
| Recruiting | 4 | 55 | RoW | Finerenone, Nifedipine | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Primary Aldosteronism, Finerenone, Mineralocorticoid Receptor Antagonist | 03/27 | 04/27 | | |
NCT06256289: Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome |
|
|
| Not yet recruiting | 4 | 50 | NA | Canagliflozin 100mg Tab, Invokana, Metformin Hydrochloride, Glucophage | Ping Li,MD | Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease | 04/25 | 04/25 | | |
NCT04939441: Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF) |
|
|
| Active, not recruiting | 4 | 100 | RoW | Tenofovir alafenamide, Vemlidy® | Jidong Jia, Beijing Ditan Hospital, ShuGuang Hospital, Tianjin Third Central Hospital, Huashan Hospital, The Sixth Peoples Hospital of Zhengzhou, Tianjin Second People's Hospital, Ruijin Hospital, Shanghai East Hospital | Chronic Hepatitis B | 05/24 | 05/25 | | |
NCT05814770: Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism |
|
|
| Not yet recruiting | 4 | 96 | NA | Finerenone, Kerendia, Spironolactone | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, National Key Research and Development Program of China, National Natural Science Foundation of China | Primary Aldosteronism, Hypertension | 03/25 | 03/26 | | |
NDKD, NCT06110130: Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With |
|
|
| Recruiting | 4 | 60 | US | Empagliflozin 10 MG, Placebo | Washington D.C. Veterans Affairs Medical Center, Boehringer Ingelheim | Chronic Kidney Diseases | 12/25 | 12/26 | | |
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients |
|
|
| Recruiting | 4 | 5000 | RoW | Peginterferon Alfa-2B, Nucleoside Analogs | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Chronic | 12/26 | 11/29 | | |
NCT04373967: Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes |
|
|
| Recruiting | 3 | 424 | RoW | Victoza®., Metformin Hydrochloride, TQZ2451 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Type 2 Diabetes | 12/21 | 12/21 | | |
| Completed | 3 | 533 | RoW | Chiglitazar 32mg, Bilessglu, CS038, Chiglitazar 48mg, Placebo, Chiglitazar simulator, Metformin Hydrochloride, Glucophage | Chipscreen Biosciences, Ltd. | Type 2 Diabetes | 02/23 | 02/23 | | |
NCT06280716: A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis |
|
|
| Recruiting | 3 | 430 | RoW | Placebo, Lebrikizumab, LY3650150, Topical Corticosteroid | Eli Lilly and Company | Atopic Dermatitis | 12/25 | 11/26 | | |
TRAPP, NCT05811676: Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women with Placenta Previa |
|
|
| Recruiting | 3 | 1680 | RoW | Tranexamic acid, 0.9% sodium chloride | Guangzhou Medical University, Dongguan Maternal and Child Health Care Hospital, Foshan Women and Children Hospital, BoAi Hospital of Zhongshan, Women and Children's Hospital of Chongqing Medical University, Tianjin Central Hospital of Gynecology Obstetrics, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Urumqi Maternal and Child Health Care Hospital, Zhuhai Women and Children's Hospital, The First Affiliated Hospital of Zhengzhou University, Hunan Provincial Maternal and Child Health Care Hospital, Dalian women and children's medical group, Nanfang Hospital, Southern Medical University, Huadu District People's Hospital of Guangzhou, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, First Affiliated Hospital, Sun Yat-Sen University, Shenzhen Maternity & Child Healthcare Hospital, Shenzhen Baoan Women's and Children's Hospital, Dongguan People's Hospital, First Affiliated Hospital of Xinjiang Medical University, Tongji Hospital, Peking Union Medical College, Peking University First Hospital, The First Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Guangzhou Medical University, Fifth Affiliated Hospital of Guangzhou Medical University, Shijiazhuang Obstetrics and Gynecology Hospital | Hemorrhage, Postpartum, Placenta Previa | 02/25 | 04/25 | | |
NCT06631170: Efficacy and Safety of Roflumilast Cream in Subjects with Atopic Dermatitis |
|
|
| Recruiting | 3 | 351 | RoW | Roflumilast Cream 0.15%, Vehicle cream | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Atopic Dermatitis (AD) | 08/25 | 08/25 | | |
ACHIEVE, NCT04808752: Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases |
|
|
| Active, not recruiting | 2 | 63 | RoW | Almonertinib, Investigational Product | Zhejiang Cancer Hospital, Jiangsu Hansoh Pharmaceutical Co., Ltd. | Lung Cancer | 06/24 | 07/24 | | |
NCT06677879: A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer. |
|
|
| Recruiting | 2 | 780 | RoW | Proton radiotherapy, Photon radiotherapy | Shanghai Proton and Heavy Ion Center | Breast Cancer | 07/26 | 07/28 | | |
TQB3702-II-02, NCT06566586: A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma |
|
|
| Recruiting | 2 | 80 | RoW | TQB3702 tablets+Chemotherapy regimen | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | B-cell Lymphoma | 03/26 | 12/27 | | |
| Recruiting | 2 | 54 | RoW | proton plus carbon ion radiation | Shanghai Proton and Heavy Ion Center | Prostate Cancer | 05/25 | 05/26 | | |
| Recruiting | 2 | 140 | RoW | carbon ion irradation, Carbon Ion Irradiation With SIB | Shanghai Proton and Heavy Ion Center | Localized Prostate Cancer | 07/25 | 07/28 | | |
| Suspended | 2 | 279 | Europe, US, RoW | zetomipzomib, KZR-616, placebo, matching placebo | Kezar Life Sciences, Inc. | Lupus Nephritis | 05/26 | 07/26 | | |
SPHIC-TR-BCa2022-02, NCT05692674: A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction |
|
|
| Recruiting | 2 | 67 | RoW | adjuvant hypofractionated intensity-modulated proton radiotherapy | Shanghai Proton and Heavy Ion Center | Breast Cancer | 09/28 | 09/28 | | |
| Recruiting | 1/2 | 380 | RoW | PM8002 | Biotheus Inc. | Malignant Neoplasm | 11/25 | 11/25 | | |
| Recruiting | 1 | 30 | RoW | carbon ion radiotherapy | Shanghai Proton and Heavy Ion Center | Radiotherapy, Prostate Cancer | 12/22 | 06/23 | | |
NCT06375161: Anti-CD19-CAR-T Cells in Relapsed/Refractory B-cell Tumor Patients. |
|
|
| Recruiting | 1 | 12 | RoW | anti-CD19-CAR-T cells | Shanghai Tongji Hospital, Tongji University School of Medicine | B Cell Malignancies | 12/25 | 12/39 | | |
NCT04606433: Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia |
|
|
| Recruiting | 1 | 41 | RoW | GNC-038 | Sichuan Baili Pharmaceutical Co., Ltd., SystImmune Inc. | Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia | 06/25 | 11/25 | | |
| Recruiting | 1 | 92 | RoW | TQB2223 injection+ Penpulimab Injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Cancer | 01/25 | 01/26 | | |
NCT05924750: A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia |
|
|
| Recruiting | 1 | 26 | RoW | BL-M11D1 | Sichuan Baili Pharmaceutical Co., Ltd. | Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) | 08/25 | 08/25 | | |
| Recruiting | 1 | 24 | RoW | proton plus carbon ion radiotherapy | Shanghai Proton and Heavy Ion Center | Triple Negative Breast Cancer, HER2-positive Breast Cancer | 10/25 | 01/26 | | |
CHESS1901, NCT03990753: Microbiome/Peptidome-based Model for Non-invasive Detection of High-risk Gastroesophageal Varices in Compensated Cirrhosis (/APPHA1901) |
|
|
| Recruiting | N/A | 1000 | RoW | esophagogastroduodenoscopy | Nanfang Hospital of Southern Medical University, Southern Medical University, China, LanZhou University, Zhongda Hospital, Medical School, Southeast University, Guangdong Second Provincial General Hospital, Xingtai People's Hospital, The Third Hospital of Zhenjiang Affiliated Jiangsu University, Tianjin Second People's Hospital, Zhejiang University Lishui Hospital, The Second Hospital of Anhui Medical University, The Sixth People's Hospital of Shenyang, Xi'an Gaoxin Hospital, King Chulalongkorn Memorial Hospital affiliated to Chulalongkorn University, Ankara University | Compensated Cirrhosis | 06/21 | 06/22 | | |
| Not yet recruiting | N/A | 5000 | RoW | Endovascular Therapy | Chinese Academy of Medical Sciences, Fuwai Hospital | Renal Artery Obstruction, Hypertension, Renovascular | 04/22 | 04/24 | | |
NCT04108169: Association Between S-LAAO and Adverse Cardiovascular Events Among Patients Undergoing Coronary Artery Bypass Grafting. |
|
|
| Recruiting | N/A | 240 | RoW | Left atrial appendage occlusion surgery | Beijing Institute of Heart, Lung and Blood Vessel Diseases | Heart Surgery | 10/22 | 01/23 | | |
NCT02739659: Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer |
|
|
| Recruiting | N/A | 73 | RoW | carbon-ion radiotherapy | Shanghai Proton and Heavy Ion Center | Prostate Carcinoma | 12/22 | 12/24 | | |
NCT05392712: Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis |
|
|
| Recruiting | N/A | 430 | RoW | Magnetometer | Qilu Hospital of Shandong University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Weifang People's Hospital, Linyi People's Hospital, Jining First People's Hospital, The First Affiliated Hospital with Nanjing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital Xi'an Jiaotong University, Chongqing Emergency Medical Center, Guangdong Provincial Hospital of Traditional Chinese Medicine, First People's Hospital of Hangzhou, Central hospital Affiliated to Shandong First Medical University, Weihai Central Hospital, Heze Municipal Hospital | Chest Pain, Acute Coronary Syndrome, Myocardial Infarction | 08/24 | 12/24 | | |
NCT06142175: Relmacabtagene Autoleucel in Patients With LBCL |
|
|
| Recruiting | N/A | 200 | RoW | Relmacabtagene Autoleucel, JWCAR029 | Shanghai Ming Ju Biotechnology Co., Ltd. | Large B-cell Lymphoma | 12/24 | 12/24 | | |
ASORPWICE, NCT03521739: Association of Synchronous Four-limb blOod pRessure and Pulse Wave velocIty With Cardiovascular Events |
|
|
| Recruiting | N/A | 100000 | RoW | | Chinese Academy of Medical Sciences, Fuwai Hospital | Blood Pressure, Pulse Wave Analysis, Ankle Brachial Index, Patient Outcome Assessment | 12/22 | 12/23 | | |
NCT04833192: Evaluation of New Diagnostic Indicator of Subclinical Hypercortisolism |
|
|
| Recruiting | N/A | 202 | RoW | experimental group | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Adrenal Incidentaloma, Subclinical Hypercortisolism | 04/23 | 12/23 | | |
NCT05826080: Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism |
|
|
| Recruiting | N/A | 59 | RoW | | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Primary Aldosteronism, Aldosterone-Producing Adenoma, Idiopathic Hyperaldosteronism | 10/23 | 09/24 | | |
NCT05896826: Magnetocardiography in the Accurate Identification of Myocardial Infarction |
|
|
| Recruiting | N/A | 500 | RoW | Magnetometer | Qilu Hospital of Shandong University, Chongqing Emergency Medical Center, Weifang People's Hospital, Linyi People's Hospital, Weihai Central Hospital, Jining First People's Hospital, The First Affiliated Hospital with Nanjing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital Xi'an Jiaotong University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Central hospital Affiliated to Shandong First Medical University, Heze Municipal Hospital, First People's Hospital of Hangzhou | Chest Pain, Acute Coronary Syndrome, Myocardial Infarction | 10/24 | 12/24 | | |
| Recruiting | N/A | 240 | RoW | Carvedilol 12.5 MG, Nucleos(t)ide Analogues | Beijing Friendship Hospital | Liver Cirrhosis, Portal Hypertension | 10/24 | 10/24 | | |
TAILOR-TAVR, NCT05511792: Down Sizing Strategy (HANGZHOU Solution) vs Standard Sizing Strategy TAVR in Bicuspid Aortic Stenosis (Type 0) |
|
|
| Recruiting | N/A | 206 | RoW | TAVR for BAV Using Down Sizing with the Evolut Pro platform, Down Sizing Strategy, TAVR for BAV Using Traditional Sizing strategy with the Evolut Pro platform, Standard Sizing Strategy | Second Affiliated Hospital, School of Medicine, Zhejiang University | Aortic Stenosis With Bicuspid Valve | 06/25 | 06/29 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
NCT03261934: Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation |
|
|
| Recruiting | N/A | 2000 | RoW | No intervention | Beijing University of Chinese Medicine, The University of Science and Technology of China, China Academy of Chinese Medical Sciences, Harvard Medical School (HMS and HSDM) | Risk Assessment of Chronic Atrophic Gastritis Malignant Transformation | 12/30 | 12/30 | | |
ACTRN12622000019707: Effects of recorded maternal voice on heart rate and anthropometric parameters in premature infants: A randomized controlled trial |
|
|
| Completed | N/A | 108 | | | Ping Li, Ping Li | heart rate, anthropometric parameters | | | | |
NCT04289701: Hypertension Registry of "Hypertension Prevention and Control Initiative in China" |
|
|
| Recruiting | N/A | 200000 | RoW | Health Services for Systematic Hypertension Management | Chinese Academy of Medical Sciences, Fuwai Hospital | Hypertension | 12/22 | 12/24 | | |
NCT05357456: Performances on Cognitive Functions and Brain Function and Follow-up After Different Treatments in Patients With Autonomous Cortisol Secretion: a Single-center, Prospective, Observational Study |
|
|
| Recruiting | N/A | 62 | RoW | Cognitive function assessment; functional magnetic resonance imaging, fMRI, laparoscopic adrenal surgery | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Autonomous Cortisol Secretion, Adrenal Incidentaloma, Non-functioning Adrenal Adenomas | 10/24 | 10/26 | | |
| Yu, Chen |
NCT06552520: To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis |
|
|
| Not yet recruiting | 3 | 500 | RoW | TQH2722 injection, Placebo of TQH2722 injection | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | Atopic Dermatitis | 10/25 | 06/26 | | |
NCT05136456: Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy |
|
|
| Active, not recruiting | 2 | 61 | RoW | SHR1459 Low Dose, SHR1459 High Dose, Placebo | Reistone Biopharma Company Limited | Primary Membranous Nephropathy | 08/23 | 03/24 | | |
| Recruiting | 2 | 140 | RoW | WS016 3g, WS016 6g, WS016 12g, Matching Placebo | Waterstone Pharmaceutical (Wuhan) Co., LTD. | Hyperkalemia | 04/24 | 08/24 | | |
NCT05970432: A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis |
|
|
| Recruiting | 2 | 160 | RoW | TQH2722 injection 300mg-150mg, TQH2722 injection 600mg-300mg, TQH2722 injection 900mg-450mg, TQH2722 injection matching Placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Atopic Dermatitis | 03/24 | 03/24 | | |
NCT04905602: A Trial of SHR-1905 in Healthy Subjects and Subjects With Mild Asthma |
|
|
| Completed | 1 | 86 | RoW | SHR-1905/placebo | Shanghai Hengrui Pharmaceutical Co., Ltd. | Asthma | 10/23 | 10/23 | | |
NCT05753033: The Pharmacokinetics (PK), Safety, Tolerability of SR750 in Healthy Volunteers |
|
|
| Completed | 1 | 56 | RoW | SR750 tablet, Placebo | Shanghai SIMR Biotechnology Co., Ltd. | Healthy | 09/23 | 09/23 | | |
NCT05895812: A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function |
|
|
| Completed | 1 | 24 | RoW | Deuremidevir Hydrobromide Tablets | Shanghai Vinnerna Biosciences Co., Ltd., Sponsor GmbH | Subjects With Renal Impairment, Healthy Subjects | 08/23 | 08/23 | | |
NCT06070857: Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers |
|
|
| Recruiting | 1 | 48 | RoW | LV232, Placebo | Vigonvita Life Sciences | Healthy Subjects | 12/24 | 12/24 | | |
NCT06279533: Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules |
|
|
| Recruiting | 1 | 48 | RoW | LV232/Placebo, LV232 | Vigonvita Life Sciences | Healthy Subjects | 12/24 | 12/24 | | |
| Recruiting | N/A | 2500 | RoW | | Gang Wang, MD | Psoriasis Patients, COVID-19 | 05/23 | 07/23 | | |
MATCH, NCT04572568: Registry of Multimodality Treatment for Brain Arteriovenous Malformation in Mainland China |
|
|
| Recruiting | N/A | 2000 | RoW | Multi-disciplinary assessment | Beijing Tiantan Hospital, Beijing Neurosurgical Institute, Peking University International Hospital, West China Hospital, First Affiliated Hospital of Harbin Medical University, Sichuan Provincial People's Hospital, The First Hospital of Jilin University, Shanxi Provincial People's Hospital, The Second Hospital of Shandong University, The First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Xinjiang Medical University, The General Hospital of Central Theater Command, The Affiliated Hospital Of Guizhou Medical University, First Affiliated Hospital of Guangxi Medical University, Tianjin Medical University Second Hospital, The First Affiliated Hospital of Shanxi Medical University, Shengjing Hospital, Second Affiliated Hospital of Guangzhou Medical University, Hainan People's Hospital, The Second Affiliated Hospital of Kunming Medical University, The Affiliated Hospital of Qingdao University, Second Xiangya Hospital of Central South University, Second Affiliated Hospital of Soochow University, General Hospital of Ningxia Medical University, Second Hospital of Lanzhou University, The First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital of Zhejiang University, Qilu Hospital of Shandong University, Jining Medical University, First Affiliated Hospital of Chongqing Medical University, First Affiliated Hospital of Fujian Medical University, Shandong Provincial Hospital, The Affiliated Hospital of Xuzhou Medical University, Henan Provincial People's Hospital, Binzhou Medical University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Brain Arteriovenous Malformation | 04/32 | 04/33 | | |
| Jiang, Hong |
NCT06083623: A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants |
|
|
| Not yet recruiting | 2b | 2250 | RoW | TNM001, placebo | Zhuhai Trinomab Pharmaceutical Co., Ltd. | Respiratory Syncytial Virus Infections | 05/26 | 08/26 | | |
ALTER-G-001, NCT05262335: Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis |
|
|
| Recruiting | 2 | 116 | RoW | Anlotinib + Oxaliplatin + Capecitabine, Anlotinib + Cisplatin + Paclitaxel/ Docetaxel, Anlotinib + Standard first-line chemotherapy | Ruijin Hospital, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Gastrointestinal Tumors | 12/23 | 12/24 | | |
NCT03378414: Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia |
|
|
| Not yet recruiting | 2 | 45 | NA | Intravenous infusion, Intrathecal injection, umbilical cord mesenchymal stem cell | Sclnow Biotechnology Co., Ltd. | Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia Type 6 | 06/25 | 12/25 | | |
NCT06048588: YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis |
|
|
| Recruiting | 1/2 | 130 | RoW | YN001, Placebo for YN001, Placebo, rosuvastatin calcium tablets, Crestor® | Beijing Inno Medicine Co., Ltd. | Atherosclerotic Cardiovascular Disease | 12/24 | 04/25 | | |
NCT04658992: The Registration on the Use of Feilike Heji in Minors |
|
|
| Recruiting | N/A | 3000 | RoW | | China Academy of Chinese Medical Sciences | Bronchial Asthma | 12/21 | 03/22 | | |
UltraFuture I, NCT05498740: Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia |
|
|
| Recruiting | N/A | 200 | RoW | Drug eluting Balloon | Zhejiang Zylox Medical Device Co., Ltd. | Peripheral Arterial Disease (PAD) | 12/22 | 12/24 | | |
NCT05073549: Optimizing Antibiotic Use in Neonatal Intensive Care Units in China |
|
|
| Recruiting | N/A | 10000 | RoW | Collaborative Antimicrobial Stewardship Program (ASP) | Children's Hospital of Fudan University, China Medical Board | Neonates | 09/23 | 12/23 | | |
NCT05415995: A Trail of Drug-coated Balloon Treating Below The Knee Arterial Diseases |
|
|
| Recruiting | N/A | 202 | RoW | Drug eluting Balloon | Zhejiang Zylox Medical Device Co., Ltd. | Peripheral Artery Disease | 12/23 | 12/24 | | |
NCT06357026: Phitys I™ Percutaneous Left Ventricular Assist System Study |
|
|
| Not yet recruiting | N/A | 344 | RoW | Percutaneous Ventricular Assist System（Phigine Medical）, intra-aortic balloon pump (IABP) | Shanghai NewMed Medical Co., Ltd., Shanghai Phigine Medical Technology Co., Ltd. | Coronary Artery Disease | 05/25 | 04/26 | | |
NCT04458220: Research on Early Warning and Solution System of Difficult Airway in Perioperative Period Based on Artificial Intelligence |
|
|
| Recruiting | N/A | 16000 | RoW | photo and voice obtained | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Difficult Airway | 05/24 | 05/25 | | |
NCT06101888: Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR) |
|
|
| Recruiting | N/A | 116 | RoW | TaurusTrio™ Heart Valve System | Peijia Medical Technology (Suzhou) Co., Ltd. | Aortic Regurgitation | 07/24 | 07/29 | | |
NCT06639321: Phimume® Percutaneous Left Ventricular Assist System Study |
|
|
| Not yet recruiting | N/A | 250 | RoW | Percutaneous Ventricular Assist System, extracorporeal membrane oxygenation (ECMO) | Shanghai NewMed Medical Co., Ltd., Shanghai Phigine Medical Technology Co., Ltd. | Coronary Artery Disease | 11/25 | 10/26 | | |
NCT06039748: Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study |
|
|
| Not yet recruiting | N/A | 330 | NA | AngioQFA | Shenzhen Raysight Intelligent Medical Technology Co., Ltd., Renmin Hospital of Wuhan University, Yan'an Affiliated Hospital of Kunming Medical University, Sir Run Run Shaw Hospital, The Eighth Affiliated Hospital of Sun Yat-sen University, Jieyang People's Hospital | Coronary Artery Disease, Heart Diseases, Cardiovascular Diseases, Arteriosclerosis, Coronary Stenosis, Vascular Diseases, Ischemia | 10/24 | 10/24 | | |
NCT05649488: Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus |
|
|
| Recruiting | N/A | 184 | RoW | Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus, Dragonfly Opstar Imaging Catheter | Shanghai Bluesail Boyuan Medical Technology Co., Ltd. | Coronary Artery Disease, Intravascular Lithotripsy | 12/24 | 09/25 | | |
| Recruiting | N/A | 6254 | Europe, Japan, US, RoW | Tight pressure management, Routine pressure management | The Cleveland Clinic | Blood Pressure | 12/26 | 04/27 | | |
NCT04456985: Effect of Preoperative Intervention With Folic Acid and Vitamin B12 on Postoperative Neurobehavioral Changes in Children |
|
|
| Recruiting | N/A | 360 | RoW | Folic acid and vitamin B12, brown sugar aqueous | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Delirium | 06/25 | 06/25 | | |
NCT05207254: Research on the Application of Artificial Intelligence Ultrasonic Recognition Technology in Difficult Airway Assessment |
|
|
| Recruiting | N/A | 4000 | RoW | Ultrasonic test | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Difficult Airways | 12/25 | 12/25 | | |
NCT05694091: Correlation of Perioperative Brain Metabolites With Postoperative Delirium in Elderly Oral Craniomaxillofacial Surgery Patients |
|
|
| Recruiting | N/A | 46 | RoW | Collecting clinical data, blood gas data, Magnetic Resonance Spectroscopy (MRS) data and blood,urine, and feces sample | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Delirium in Old Age | 12/25 | 12/25 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
| Not yet recruiting | N/A | 550 | RoW | lymph node dissection, Fluorescence-guided laparoscopic surgery, Radical operation for rectal cancer and sigmoid Cancer | Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Fudan University, Fujian Province Tumor Hospital, Guangdong Provincial People's Hospital, Shengjing Hospital, Affiliated Hospital of Qinghai University, Hebei Medical University Fourth Hospital, The Second Affiliated Hospital of Harbin Medical University, Jiangxi Provincial Cancer Hospital, The First Hospital of Jilin University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Shanxi Province Cancer Hospital, Nanfang Hospital, Southern Medical University, Second People's Hospital of Yunnan Province, Binzhou Medical University, The First Affiliated Hospital of University of Science and Technology of China, First Affiliated Hospital of Chengdu Medical College, The Second People's Hospital of Yibin, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Colorectal Neoplasms, Fluorescence, Lymph Node Excision | 12/26 | 06/27 | | |
NCT05105451: Study on the Characteristics of Non-targeted Metabolomics and EEG of Delayed Neurocognitive Recovery in Elderly Patients |
|
|
| Active, not recruiting | N/A | 80 | RoW | Collecting clinical data, EGG，arterial blood gas data and venous blood sample | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Delayed Neurocognitive Recovery | 12/26 | 12/26 | | |
NCT05555693: Correlation Between Postoperative Cognitive-related Adverse Reactions and Brain Metabolomic Characteristics in Elderly Patients |
|
|
| Recruiting | N/A | 200 | RoW | Collecting clinical data, EGG，Brain Metabolomic Characteristics(with Magnetic Resonance Spectroscopy), blood gas data and blood sample | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | POCD - Postoperative Cognitive Dysfunction | 01/27 | 12/27 | | |
| Chen, Liming |
QWINT-2, NCT05362058: A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time |
|
|
| Completed | 3 | 928 | Europe, Canada, Japan, US, RoW | Insulin Efsitora Alfa, LY3209590 and Basal Insulin-FC, Insulin Degludec | Eli Lilly and Company | Diabetes, Type 2 Diabetes | 04/24 | 04/24 | | |
| Completed | 3 | 257 | RoW | Tirzepatide, LY3298176, Placebo | Eli Lilly and Company | Diabetes Type 2, Diabetes Mellitus, Glucose Metabolism Disorders, Metabolic Disease, Endocrine System Diseases | 07/24 | 07/24 | | |
NCT06649344: A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes |
|
|
| Recruiting | 3 | 840 | RoW | HRS9531 Injection, Semaglutide Injection | Fujian Shengdi Pharmaceutical Co., Ltd. | Type 2 Diabetes | 09/26 | 09/26 | | |
ATTAIN-2, NCT05872620: A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes |
|
|
| Active, not recruiting | 3 | 1500 | Europe, US, RoW | Orforglipron, LY3502970, Placebo | Eli Lilly and Company | Obesity, Overweight, Type 2 Diabetes | 08/25 | 08/25 | | |
ATTAIN-1, NCT05869903: A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities |
|
|
| Active, not recruiting | 3 | 3000 | Europe, Japan, US, RoW | Orforglipron, LY3502970, Placebo | Eli Lilly and Company | Obesity, Overweight, Overweight or Obesity | 07/25 | 07/27 | | |
| Wang, Xiuqin |
NCT05709093: A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS) |
|
|
| Recruiting | 3 | 552 | RoW | Lemzoparlimab+Azacitidine (AZA), Azacitidine (AZA) | TJ Biopharma Co., Ltd. | Myelodysplastic Syndromes(MDS) | 03/27 | 03/27 | | |
NCT06467851: Effect of Suanzaoren Decoction and Huanglian Wendan Decoction on Biorhythm of Insomnia Patients |
|
|
| Completed | N/A | 19 | RoW | Suanzaoren Decoction and Huanglian Wenda Decoction | The First Affiliated Hospital with Nanjing Medical University | Chronic Insomnia, Melatonin, Circadian Rhythm, Suanzaoren Decoction and Huanglian Wendan | 04/24 | 04/24 | | |
NCT06244277: Chinese Medicine Treatment of Adolescent Sleep Disorders and Sleeping Pills Withdrawal |
|
|
| Recruiting | N/A | 106 | RoW | Suanzaoren Decoction and Huanglian Wendan Decoction, Zolpidem | The First Affiliated Hospital with Nanjing Medical University | Traditional Chinese Medicine, Sleep Disorder | 12/25 | 12/25 | | |
NCT05452577: Treatment of Chronic Insomnia According to Yin Yang Theory and Its Correlation With Circadian Rhythm |
|
|
| Completed | N/A | 187 | RoW | Suanzaoren Decoction and Huanglian Wendan Decoction, Wild Jujube Seed Decoction and Huanglian Wendan Decoction, Estazolam 1Mg Tab, Estazolam, Estazolam Tablets, Estazolam Pill | The First Affiliated Hospital with Nanjing Medical University | Chronic Insomnia, Circadian Rhythm, Traditional Chinese Medicine | 05/23 | 05/23 | | |
| Sowerby, Leigh J |
NCT04869436: Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis |
|
|
| Recruiting | 4 | 27 | Canada | Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT] | London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's, Mount Sinai Hospital, Canada | Chronic Rhinosinusitis With Nasal Polyps, Olfactory Disorder | 09/25 | 12/25 | | |
NCT04147013: Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS |
|
|
| Active, not recruiting | 4 | 44 | Canada, RoW | Celecoxib, Celebrex, Placebo | Lawson Health Research Institute, Western University, Canada, London Health Sciences Centre | Chronic Rhinosinusitis with Nasal Polyps, Aspirin-exacerbated Respiratory Disease | 02/26 | 07/26 | | |
NCT06338995: A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP) |
|
|
| Recruiting | 3 | 510 | Europe, Canada, Japan, US, RoW | LY3650150, Placebo, Standard therapy for INCS | Eli Lilly and Company | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | 11/25 | 10/26 | | |
| Completed | 3 | 276 | Europe, Canada, Japan, US, RoW | Depemokimab (GSK3511294), Placebo | GlaxoSmithKline, GlaxoSmithKline Research & Development Limited | Nasal Polyps | 07/24 | 08/24 | | |
|
Stella, NCT06055270: te Ganglion Block with Lidocaine for the Treatment of COVID-19-Induced Parosmia |
|
|
| Recruiting | 3 | 44 | Canada | Stellate Ganglion Block, SGB, sympathetic block, Placebo, Placebo sham injection | Lawson Health Research Institute | Parosmia | 12/25 | 05/26 | | |
| Completed | N/A | 86 | Canada, US | Novapak Nasal Sinus Packing and Stent | Medtronic Surgical Technologies | Nasal Airway Obstruction | 12/23 | 12/23 | | |
| Lu, Jianwei |
NCT04714190: A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression |
|
|
| Recruiting | 3 | 351 | RoW | RC48-ADC, Recombinant Humanized anti-HER2 Monoclonal Antibody-MMAE Conjugate For Injection, Paclitaxel injection, Taxol, Irinotecan Hydrochloride Injection, CAMPTO, Apatinib Mesylate Tablets, Aitan | RemeGen Co., Ltd. | Gastric Cancer, HER2 Overexpressing Gastric Carcinoma | 12/24 | 06/25 | | |
NCT04385550: A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma |
|
|
| Not yet recruiting | 3 | 528 | RoW | Anlotinib hydrochloride capsule, AK105 injection, Paclitaxel injection, Docetaxel injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma | 10/23 | 12/23 | | |
NCT05180734: PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer |
|
|
| Active, not recruiting | 3 | 878 | RoW | JS001/Placebo, Postoperative Adjuvant Chemotherapy, JS001/placebo combine with Postoperative Adjuvant Chemotherapy | Shanghai Junshi Bioscience Co., Ltd. | Gastric or Esophagogastric Junction Adenocarcinoma | 06/26 | 07/28 | | |
NCT04603040: A Study to Evaluate the Efficacy and Safety of Toripalimab Injection in the Treatment of Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy and Are Positive Specific Markers |
|
|
| Recruiting | 2 | 100 | RoW | Toripalimab, Tuoyi | Shanghai Junshi Bioscience Co., Ltd. | Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy | 12/22 | 03/23 | | |
| Liang, Aibin |
NCT04684147: Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia |
|
|
| Recruiting | 2 | 100 | RoW | single dose of CNCT19 | Juventas Cell Therapy Ltd. | Relapsed or Refractory Acute Lymphoblastic Leukemia | 09/22 | 12/26 | | |
NCT04324879: A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL) |
|
|
| Recruiting | 2 | 80 | RoW | TQ-B3525 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Relapsed / Refractory Follicular Lymphoma | 12/22 | 12/22 | | |
NCT04586478: Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma |
|
|
| Recruiting | 2 | 60 | RoW | single dose of CNCT19 | Juventas Cell Therapy Ltd. | Non-Hodgkin's Lymphoma | 12/24 | 09/25 | | |
NCT06182696: OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM |
|
|
| Recruiting | 1/2 | 83 | RoW | OriCAR-017 | OriCell Therapeutics Co., Ltd. | Relapsed and/or Refractory Multiple Myeloma | 11/26 | 08/28 | | |
| Active, not recruiting | 1/2 | 121 | RoW | CAR-BCMA T Cells | CARsgen Therapeutics Co., Ltd., Beijing Chao Yang Hospital, The First Affiliated Hospital of Soochow University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Tianjin Medical University General Hospital, First Affiliated Hospital of Zhejiang University, Beijing Hospital, Shanghai Tongji Hospital, Tongji University School of Medicine, First Affiliated Hospital of Wenzhou Medical University, Xiangya Hospital of Central South University, Peking University People's Hospital, Qilu Hospital of Shandong University, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University | Multiple Myeloma | 12/24 | 12/25 | | |
| Recruiting | 1/2 | 120 | RoW | Chidamide, HDACi, Fludarabine and cyclophosphamide, FC regimen, Anti-CD19 CAR-T cells, Relma-cel, Axi-cel, Other commercial CAR-T cells, Experimental CAR-T cells | Chinese PLA General Hospital | Non Hodgkin's Lymphoma | 06/24 | 06/25 | | |
